Wang, 2024 ChiCTR2000037655
sintilimab (n=99) vs. Standard of Care (SoC) (n=99)
randomized controlled trial
sintilimab
sintilimab injections every 3 weeks for a total of eight cycles
SOc
active surveillance
mHCC - (neo)adjuvant (NA)
open label
China, 6 centers